TY  - GEN
AU  - Kharfan-Dabaja,Mohamed A
AU  - Hamadani,Mehdi
AU  - Reljic,Tea
AU  - Pyngolil,Rachel
AU  - Komrokji,Rami S
AU  - Lancet,Jeffrey E
AU  - Fernandez,Hugo F
AU  - Djulbegovic,Benjamin
AU  - Kumar,Ambuj
TI  - Gemtuzumab ozogamicin for treatment of newly diagnosed acute myeloid leukaemia: a systematic review and meta-analysis
SN  - 1365-2141
PY  - 2013///1203
KW  - Aminoglycosides
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Disease-Free Survival
KW  - Evidence-Based Medicine
KW  - Gemtuzumab
KW  - Hepatic Veno-Occlusive Disease
KW  - chemically induced
KW  - Humans
KW  - Leukemia, Myeloid, Acute
KW  - drug therapy
KW  - Leukemia, Myelomonocytic, Acute
KW  - Randomized Controlled Trials as Topic
KW  - statistics & numerical data
KW  - Remission Induction
KW  - Safety-Based Drug Withdrawals
KW  - Survival Analysis
KW  - Treatment Outcome
KW  - United States
KW  - United States Food and Drug Administration
N1  - Publication Type: Journal Article; Meta-Analysis; Review; Systematic Review
UR  - https://doi.org/10.1111/bjh.12528
ER  -